Glycopyrrolate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Glycopyrrolate Injection (injection) from Fresenius Kabi USA, LLC with status To Be Discontinued. The shortage was first posted on Jul 30, 2026.
Shortage details
- Status
- To Be Discontinued
- Company
- Fresenius Kabi USA, LLC
- Package NDC
- 65219-801-01
- Dosage Form
- Injection
- Presentation
- Glycopyrrolate, Injection, 0.2 mg per 1 mL (NDC 65219-801-01)
- Initial Posting
- Jul 30, 2026